Gliadin Peptides As Triggers of the Proliferative and Stress/innate Immune Response of the Celiac Small Intestinal Mucosa

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2014 Nov 12

PMID 25387079

Citations 47

Authors

Maria Vittoria Barone

Riccardo Troncone

Salvatore Auricchio

Affiliations

Soon will be listed here.

Abstract

Celiac disease (CD) is a frequent inflammatory intestinal disease, with a genetic background, caused by gliadin-containing food. Undigested gliadin peptides induce innate and adaptive T cell-mediated immune responses. The major mediator of the stress and innate immune response to gliadin peptides (i.e., peptide 31-43, P31-43) is the cytokine interleukin-15 (IL-15). The role of epithelial growth factor (EGF) as a mediator of enterocyte proliferation and the innate immune response has been described. In this paper, we review the most recent literature on the mechanisms responsible for triggering the up-regulation of these mediators in CD by gliadin peptides. We will discuss the role of P31-43 in enterocyte proliferation, structural changes and the innate immune response in CD mucosa in cooperation with EGF and IL-15, and the mechanism of up-regulation of these mediators related to vesicular trafficking. We will also review the literature that focuses on constitutive alterations of the structure, signalling/proliferation and stress/innate immunity pathways of CD cells. Finally, we will discuss how these pathways can be triggered by gliadin peptide P31-43 in controls, mimicking the celiac cellular phenotype.

Citing Articles

Role of Protein Tyrosine Phosphatases in Inflammatory Bowel Disease, Celiac Disease and Diabetes: Focus on the Intestinal Mucosa.

Bellomo C, Furone F, Rotondo R, Ciscognetti I, Carpinelli M, Nicoletti M Cells. 2024; 13(23).

PMID: 39682729 PMC: 11640621. DOI: 10.3390/cells13231981.

Celiac disease: Pathogenesis, disease management and new insights into the herbal-based treatments.

Mittal P, Arora D, Parashar S, Goyal R, Khan A, Chopra H Narra J. 2024; 3(2):e147.

PMID: 38454981 PMC: 10919711. DOI: 10.52225/narra.v3i2.147.

The Emerging Role of Innate Lymphoid Cells (ILCs) and Alarmins in Celiac Disease: An Update on Pathophysiological Insights, Potential Use as Disease Biomarkers, and Therapeutic Implications.

Rizzi A, Di Gioacchino M, Gammeri L, Inchingolo R, Chini R, Santilli F Cells. 2023; 12(14).

PMID: 37508573 PMC: 10378400. DOI: 10.3390/cells12141910.

Unraveling the celiac disease-related immunogenic complexes in a set of wheat and tritordeum genotypes: implications for low-gluten precision breeding in cereal crops.

Marin-Sanz M, Barro F, Sanchez-Leon S Front Plant Sci. 2023; 14:1171882.

PMID: 37251754 PMC: 10210591. DOI: 10.3389/fpls.2023.1171882.

The protective role of GG postbiotic on the alteration of autophagy and inflammation pathways induced by gliadin in intestinal models.

Furone F, Bellomo C, Carpinelli M, Nicoletti M, Hewa-Munasinghege F, Mordaa M Front Med (Lausanne). 2023; 10:1085578.

PMID: 37215707 PMC: 10192745. DOI: 10.3389/fmed.2023.1085578.

References

Yokoyama S, Watanabe N, Sato N, Perera P, Filkoski L, Tanaka T . Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Proc Natl Acad Sci U S A. 2009; 106(37):15849-54. PMC: 2736142. DOI: 10.1073/pnas.0908834106. View

Jabri B, de Serre N, Cellier C, Evans K, Gache C, Carvalho C . Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology. 2000; 118(5):867-79. PMC: 7095198. DOI: 10.1016/s0016-5085(00)70173-9. View

Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M . Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology. 2000; 119(4):996-1006. DOI: 10.1053/gast.2000.18149. View

Nanayakkara M, Lania G, Maglio M, Kosova R, Sarno M, Gaito A . Enterocyte proliferation and signaling are constitutively altered in celiac disease. PLoS One. 2013; 8(10):e76006. PMC: 3799793. DOI: 10.1371/journal.pone.0076006. View

Troncone R, Franzese A, Mazzarella G, Paparo F, Auricchio R, Coto I . Gluten sensitivity in a subset of children with insulin dependent diabetes mellitus. Am J Gastroenterol. 2003; 98(3):590-5. DOI: 10.1111/j.1572-0241.2003.07301.x. View

Sander G, Cummins A, Henshall T, Powell B . Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBS Lett. 2005; 579(21):4851-5. DOI: 10.1016/j.febslet.2005.07.066. View

Capuano M, Iaffaldano L, Tinto N, Montanaro D, Capobianco V, Izzo V . MicroRNA-449a overexpression, reduced NOTCH1 signals and scarce goblet cells characterize the small intestine of celiac patients. PLoS One. 2011; 6(12):e29094. PMC: 3240641. DOI: 10.1371/journal.pone.0029094. View

Hayden M, Ghosh S . NF-κB in immunobiology. Cell Res. 2011; 21(2):223-44. PMC: 3193440. DOI: 10.1038/cr.2011.13. View

Iltanen S, Rantala I, Laippala P, Holm K, Partanen J, Maki M . Expression of HSP-65 in jejunal epithelial cells in patients clinically suspected of coeliac disease. Autoimmunity. 2000; 31(2):125-32. DOI: 10.3109/08916939908994056. View

10.

Wapenaar M, Monsuur A, van Bodegraven A, Weersma R, Bevova M, Linskens R . Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut. 2007; 57(4):463-7. DOI: 10.1136/gut.2007.133132. View

11.

Rivabene R, Mancini E, De Vincenzi M . In vitro cytotoxic effect of wheat gliadin-derived peptides on the Caco-2 intestinal cell line is associated with intracellular oxidative imbalance: implications for coeliac disease. Biochim Biophys Acta. 1999; 1453(1):152-60. DOI: 10.1016/s0925-4439(98)00095-7. View

12.

Bjarnason I, Peters T . In vitro determination of small intestinal permeability: demonstration of a persistent defect in patients with coeliac disease. Gut. 1984; 25(2):145-50. PMC: 1432264. DOI: 10.1136/gut.25.2.145. View

13.

Clemente M, De Virgiliis S, Kang J, Macatagney R, Musu M, Di Pierro M . Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut. 2003; 52(2):218-23. PMC: 1774976. DOI: 10.1136/gut.52.2.218. View

14.

Hue S, Mention J, Monteiro R, Zhang S, Cellier C, Schmitz J . A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity. 2004; 21(3):367-77. DOI: 10.1016/j.immuni.2004.06.018. View

15.

Schulzke J, Bentzel C, Schulzke I, Riecken E, Fromm M . Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatr Res. 1998; 43(4 Pt 1):435-41. DOI: 10.1203/00006450-199804000-00001. View

16.

Belhadj Hmida N, Ben Ahmed M, Moussa A, Ben Rejeb M, Said Y, Kourda N . Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?. Am J Gastroenterol. 2011; 107(4):604-11. DOI: 10.1038/ajg.2011.397. View

17.

Maglio M, Mazzarella G, Barone M, Gianfrani C, Pogna N, Gazza L . Immunogenicity of two oat varieties, in relation to their safety for celiac patients. Scand J Gastroenterol. 2011; 46(10):1194-205. DOI: 10.3109/00365521.2011.603159. View

18.

Grunewald T, Pasedag S, Butt E . Cell Adhesion and Transcriptional Activity - Defining the Role of the Novel Protooncogene LPP. Transl Oncol. 2009; 2(3):107-16. PMC: 2730141. DOI: 10.1593/tlo.09112. View

19.

Barone M, Nanayakkara M, Paolella G, Maglio M, Vitale V, Troiano R . Gliadin peptide P31-43 localises to endocytic vesicles and interferes with their maturation. PLoS One. 2010; 5(8):e12246. PMC: 2923621. DOI: 10.1371/journal.pone.0012246. View

20.

Sollid L . Molecular basis of celiac disease. Annu Rev Immunol. 2000; 18:53-81. DOI: 10.1146/annurev.immunol.18.1.53. View